New Report Documents 2014 Hemophilia Pipeline
This morning, Business Wire released a statement from Research and Markets, the “One-Stop-Shop” for market research reports and industry newsletters from…
Posts by Category: News
Hemophilia B Drug Report Published in New England Journal of Medicine
New data will be available on a factor replacement drug for those suffering from hemophilia B. The New England Journal…
Patients in India Still Awaiting Free Hemophilia Treatment
People of Nagpur, India and surrounding cities are still awaiting on a promise made to them years ago. Those suffering…
PHARMA/BIO-TECH UPDATE: Anemia Treatment a $4 Billion/year Industry
Recently IMS Health released its list of the top grossing drugs from October 2012 – September 2013. A handful of…
New Procedure Could Benefit West Virginia Bleeding Disorder Patients
Residents in West Virginia who had second thoughts in the past about getting a knee replacement may take another look…
PHARMA/BIO-TECH Update: Bluebird Bio Announces First Transplant for Treatment of Beta-Thalassemia & Sickle Cell Anemia
“bluebird bio, Inc” has announced that it has enrolled its first subject with the rare bleeding disorder, beta-thalassemia major, into its…
PHARMA/BIO-TECH UPDATE – Collaboration Targets New Treatment for Hemophilia A
German pharmaceutical company Biotest AG and American biotechnology firm EpiVax have announced a Collaborative Research Agreement to develop a “novel,…
PHARMA/BIO-TECH UPDATE – Biogen says FDA extends review of Long-Acting Hemo B drug
Biogen Idec announced this morning that the US Food & Drug Administration (FDA) will extend the initial Prescription Drug User…
New Device Aims to Stop Bleeding Faster
A new device to stop severe bleeding is officially out on the market and it goes by iTClamp. “The device…
PHARMA/BIO-TECH UPDATE: FDA Grants Breakthrough Status for Factor Inhibitor Antidote
The United States Food and Drug Administration (FDA) has granted Portola Pharmecueticals, Adrexanet alfa – a Factor Xa inhibitor – breakthrough…